Eczema Clinical Research Studies
Biologic Injection Study
Ages 6 months-6 years
A phase 2/3 study investigating the pharmacokinetics, safety, and efficacy of Dupilumab in patients aged ≥6 months to < 6years with severe atopic dermatitis.
ORAL MEDICATION STUDY
The main purpose of this study is to see if difelikeafalin oral tablets (taken by mouth) can reduce the intensity of itching and whether it is well tolerated in subjects with atopic dermatitis and moderate to severe pruritus. Atopic dermatitis is commonly known as eczema, pruritus is commonly known as itchy skin.
Investigational Topical Therapy
The purpose of this trial is to find out if the delgocitinib cream is safe when used in adults, adolescents, and children. Delgocitinib is believed to interfere with the activity of an enzyme called Janus Kinase (JAK), which is involved in the immune response in your body.
The purpose of this study is to evaluate the effect of an investigational drug called Tradipitant on symptoms associated with atopic dermatitis with atopic dermatitis and to assess the safety of Tradipitant.
Oral Medication compared to Biologic
The main purpose of this study is to determine if Abrocitinib (oral medication) is effective and safe at treating symptoms of eczema compared to Dupilumab (biologic). These medications are designed to treat itching, redness, oozing, dryness, and thickening of the skin.